PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

PET/MR in oncology : an introduction with focus on MR and future perspectives for hybrid imaging. / Balyasnikova, Svetlana; Löfgren, Johan; de Nijs, Robin; Zamogilnaya, Yanna; Højgaard, Liselotte; Fischer, Barbara M.

In: American Journal of Nuclear Medicine and Molecular Imaging, Vol. 2, No. 4, 2012, p. 458-74.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Balyasnikova, S, Löfgren, J, de Nijs, R, Zamogilnaya, Y, Højgaard, L & Fischer, BM 2012, 'PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging', American Journal of Nuclear Medicine and Molecular Imaging, vol. 2, no. 4, pp. 458-74.

APA

Balyasnikova, S., Löfgren, J., de Nijs, R., Zamogilnaya, Y., Højgaard, L., & Fischer, B. M. (2012). PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging. American Journal of Nuclear Medicine and Molecular Imaging, 2(4), 458-74.

Vancouver

Balyasnikova S, Löfgren J, de Nijs R, Zamogilnaya Y, Højgaard L, Fischer BM. PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging. American Journal of Nuclear Medicine and Molecular Imaging. 2012;2(4):458-74.

Author

Balyasnikova, Svetlana ; Löfgren, Johan ; de Nijs, Robin ; Zamogilnaya, Yanna ; Højgaard, Liselotte ; Fischer, Barbara M. / PET/MR in oncology : an introduction with focus on MR and future perspectives for hybrid imaging. In: American Journal of Nuclear Medicine and Molecular Imaging. 2012 ; Vol. 2, No. 4. pp. 458-74.

Bibtex

@article{b3750b52b687405a94e8af9c98c2aed9,
title = "PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging",
abstract = "After more than 20 years of research, a fully integrated PET/MR scanner was launched in 2010 enabling simultaneous acquisition of PET and MR imaging. Currently, no clinical indication for combined PET/MR has been established, however the expectations are high. In this paper we will discuss some of the challenges inherent in this new technology, but focus on potential applications for simultaneous PET/MR in the field of oncology. Methods and tracers for use with the PET technology will be familiar to most readers of this journal; thus this paper aims to provide a short and basic introduction to a number of different MRI techniques, such as DWI-MR (diffusion weighted imaging MR), DCE-MR (dynamic contrast enhanced MR), MRS (MR spectroscopy) and MR for attenuation correction of PET. All MR techniques presented in this paper have shown promising results in the treatment of patients with solid tumors and could be applied together with PET increasing the amount of information about the tissues of interest. The potential clinical benefit of applying PET/MR in staging, radiotherapy planning and treatment evaluation in oncology, as well as the research perspectives for the use of PET/MR in the development of new tracers and drugs will be discussed.",
author = "Svetlana Balyasnikova and Johan L{\"o}fgren and {de Nijs}, Robin and Yanna Zamogilnaya and Liselotte H{\o}jgaard and Fischer, {Barbara M}",
year = "2012",
language = "English",
volume = "2",
pages = "458--74",
journal = "American Journal of Nuclear Medicine and Molecular Imaging",
issn = "2160-8407",
publisher = "e-Century Publishing Corporation",
number = "4",

}

RIS

TY - JOUR

T1 - PET/MR in oncology

T2 - an introduction with focus on MR and future perspectives for hybrid imaging

AU - Balyasnikova, Svetlana

AU - Löfgren, Johan

AU - de Nijs, Robin

AU - Zamogilnaya, Yanna

AU - Højgaard, Liselotte

AU - Fischer, Barbara M

PY - 2012

Y1 - 2012

N2 - After more than 20 years of research, a fully integrated PET/MR scanner was launched in 2010 enabling simultaneous acquisition of PET and MR imaging. Currently, no clinical indication for combined PET/MR has been established, however the expectations are high. In this paper we will discuss some of the challenges inherent in this new technology, but focus on potential applications for simultaneous PET/MR in the field of oncology. Methods and tracers for use with the PET technology will be familiar to most readers of this journal; thus this paper aims to provide a short and basic introduction to a number of different MRI techniques, such as DWI-MR (diffusion weighted imaging MR), DCE-MR (dynamic contrast enhanced MR), MRS (MR spectroscopy) and MR for attenuation correction of PET. All MR techniques presented in this paper have shown promising results in the treatment of patients with solid tumors and could be applied together with PET increasing the amount of information about the tissues of interest. The potential clinical benefit of applying PET/MR in staging, radiotherapy planning and treatment evaluation in oncology, as well as the research perspectives for the use of PET/MR in the development of new tracers and drugs will be discussed.

AB - After more than 20 years of research, a fully integrated PET/MR scanner was launched in 2010 enabling simultaneous acquisition of PET and MR imaging. Currently, no clinical indication for combined PET/MR has been established, however the expectations are high. In this paper we will discuss some of the challenges inherent in this new technology, but focus on potential applications for simultaneous PET/MR in the field of oncology. Methods and tracers for use with the PET technology will be familiar to most readers of this journal; thus this paper aims to provide a short and basic introduction to a number of different MRI techniques, such as DWI-MR (diffusion weighted imaging MR), DCE-MR (dynamic contrast enhanced MR), MRS (MR spectroscopy) and MR for attenuation correction of PET. All MR techniques presented in this paper have shown promising results in the treatment of patients with solid tumors and could be applied together with PET increasing the amount of information about the tissues of interest. The potential clinical benefit of applying PET/MR in staging, radiotherapy planning and treatment evaluation in oncology, as well as the research perspectives for the use of PET/MR in the development of new tracers and drugs will be discussed.

M3 - Journal article

VL - 2

SP - 458

EP - 474

JO - American Journal of Nuclear Medicine and Molecular Imaging

JF - American Journal of Nuclear Medicine and Molecular Imaging

SN - 2160-8407

IS - 4

ER -

ID: 48468225